Orion Market Research Pvt. Ltd. info@omrglobal.com +91 780-304-0404
Help Center
Careers
Contact

COPD and Asthma Devices Market

COPD and Asthma Devices Market Size, Share & Trends Analysis Report by Product Type (Inhalation Devices, Nebulizers, Airway Clearance Devices, and Positive Airway Pressure (PAP) Devices), by Device Category (Portable Devices and Stationary Devices), by End-User (Hospitals, Homecare Settings, Specialty Respiratory Clinics, and Ambulatory Surgical Centers (ASCs)), Forecast Period (2026–2035)

Published: May 2026 | Report Code: OMR2019481 | Category : Pharmaceuticals | Delivery Format: /

Industry Overview

COPD and asthma devices market was valued at $12.5 billion in 2025 and is projected to reach $22.8 billion by 2035, growing at a CAGR of 6.3% during the forecast period (2026-2035). The market is expanding due to the increasing incidence of chronic respiratory conditions such as asthma and chronic obstructive pulmonary disease, which require continuous therapeutic management. Rising levels of air pollution and occupational exposure to respiratory irritants have further contributed to the growing patient population. Advancements in device design, including portable and user-friendly systems, have improved treatment adherence and patient convenience. Healthcare systems are placing greater emphasis on early diagnosis and long-term disease management, supporting consistent demand for respiratory care devices. In addition, the gradual shift toward home-based treatment models has strengthened adoption across non-hospital settings.

Market Dynamics

Rising Burden of Chronic Respiratory Conditions and Aging Population

The market is expanding due to the increasing prevalence of chronic respiratory disorders, particularly COPD and asthma, across aging populations. Demographic transitions in several economies have resulted in a higher proportion of elderly individuals who are more susceptible to long-term pulmonary conditions requiring continuous device-based management. Urban exposure to particulate matter, occupational hazards, and lifestyle-related risk factors has further intensified disease incidence. Clinical guidelines increasingly emphasize early diagnosis and sustained treatment adherence, thereby supporting consistent demand for inhalation and respiratory support devices. Healthcare systems are also prioritizing chronic disease management programs, which include routine monitoring and home-based therapies. This shift has strengthened device utilization across both institutional and non-institutional settings. In parallel, improvements in diagnostic screening rates are contributing to a larger treated patient pool, reinforcing steady market expansion.

Technological Advancements and Shift Toward Home-Based Care

Technological innovation in respiratory care devices has significantly influenced market growth, particularly with the introduction of portable, digitally enabled, and user-friendly systems. Manufacturers are focusing on integrating connectivity features such as dose tracking, adherence monitoring, and remote patient management into inhalers and PAP devices. This has improved clinical outcomes while enhancing patient compliance. At the same time, healthcare delivery models are gradually shifting toward home-based care to reduce hospital burden and overall treatment costs. Reimbursement frameworks in several regions now support homecare therapies, encouraging adoption of compact and efficient respiratory devices. The growing acceptance of telehealth services has further complemented this trend by enabling remote monitoring and timely intervention. These developments collectively contribute to increased device penetration across diverse patient groups.

Market Segmentation

  • Based on the product type, the market is segmented into inhalation devices, nebulizers, airway clearance devices, and positive airway pressure (PAP) devices.
  • Based on the device category, the market is segmented into portable devices and stationary devices.
  • Based on the end-user, the market is segmented into hospitals, homecare settings, specialty respiratory clinics, and ambulatory surgical centers (ASCs).

Sustained Demand for Inhalation Devices Across Therapeutic Settings

Inhalation devices represent the largest segment, driven by their role as the primary mode of drug delivery in both asthma and COPD management. Their clinical effectiveness, rapid onset of action, and ease of use have ensured widespread adoption across hospitals and homecare environments. Key players such as GlaxoSmithKline plc and AstraZeneca PLC continue to introduce advanced inhaler platforms with improved drug deposition efficiency. Recent developments include breath-actuated systems and digitally integrated inhalers designed to enhance adherence tracking. The availability of generic inhalers in emerging markets has also improved accessibility, further supporting volume growth.

Rapid Expansion of Portable Devices in Homecare Applications

Portable respiratory devices are emerging as the fastest-growing category, supported by the increasing preference for home-based treatment and mobility-focused care solutions. These devices offer flexibility, ease of handling, and compatibility with remote monitoring systems, making them suitable for long-term disease management. Companies such as ResMed Inc. and Koninklijke Philips N.V. are actively investing in compact PAP devices and connected respiratory platforms. Recent trends highlight the integration of wireless connectivity and app-based interfaces, allowing real-time tracking of therapy usage. The growing awareness of self-management practices among patients has further accelerated adoption.

Regional Outlook

The global COPD and asthma devices market is further divided by geography, including North America (the US and Canada), Europe (the UK, Germany, France, Italy, Spain, Russia, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, Australia and New Zealand, ASEAN Countries, and the Rest of Asia-Pacific), and the Rest of the World (the Middle East & Africa, and Latin America).

North America: Established Healthcare Infrastructure Driving Device Adoption

North America demonstrates a mature market landscape supported by advanced healthcare infrastructure and high awareness levels regarding respiratory disease management. The region benefits from early adoption of technologically advanced devices, particularly smart inhalers and connected PAP systems. Favorable reimbursement policies and structured disease management programs have contributed to sustained demand across clinical and homecare settings. Leading companies such as ResMed Inc. and Philips maintain a strong presence through continuous product innovation. Recent trends indicate increased integration of digital health platforms and remote monitoring solutions. Regulatory support for advanced therapeutic devices further strengthens market stability.

Asia-Pacific: Expanding Patient Base and Improving Access to Care

Asia-Pacific is experiencing notable growth due to a rising patient population and gradual improvements in healthcare accessibility. Increasing urbanization and environmental factors have contributed to higher incidence rates of respiratory conditions, creating substantial demand for treatment devices. Governments in several countries are investing in healthcare infrastructure and awareness programs aimed at early diagnosis and disease management. Regional manufacturers, along with global companies such as OMRON Healthcare Co., Ltd. and Cipla Limited, are expanding their product portfolios to cater to cost-sensitive markets. There is a growing preference for affordable and portable devices, particularly in homecare settings. Technological adoption is gradually increasing, supported by digital health initiatives and improved distribution networks.

Market Players Outlook

The major companies operating in the global COPD and asthma devices market include Koninklijke Philips N.V., ResMed Inc., GlaxoSmithKline plc , AstraZeneca PLC, Boehringer Ingelheim International GmbH, among others. Market players are leveraging partnerships, collaborations, mergers, and acquisition strategies for business expansion and innovative product development to maintain their market positioning.

Recent Developments

  • In May 2025, Lupin Limited partnered with Honeywell International Inc. to develop next-generation inhalers using Solstice Air propellant, enabling a reduction in greenhouse gas emissions by up to 99.9% while maintaining therapeutic efficiency.
  • In May 2025, AstraZeneca PLC received regulatory approval in the UK for its Trixeo Aerosphere inhaler with a next-generation low-carbon propellant, marking a significant advancement in sustainable respiratory drug delivery systems.

The Report Covers

  • Market value data analysis of 2025 and forecast to 2035.
  • Annualized market revenues ($ million) for each market segment.
  • Country-wise analysis of major geographical regions.
  • Key companies operating in the global COPD and asthma devices Based on the availability of data, information related to new products and relevant news is also available in the report.
  • Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
  • Analysis of market-entry and market expansion strategies.
  • Competitive strategies by identifying ‘who-stands-where’ in the market.
  1. Report Summary
    • Current Industry Analysis and Growth Potential Outlook
    • Global COPD and Asthma Devices Market Sales Analysis – Product Type | Device Category | End-User ($ Million)
    • COPD and Asthma Devices Market Sales Performance of Top Countries

1.1 Research Methodology
• Primary Research Approach
• Secondary Research Approach

1.2 Market Snapshot

  1. Market Overview and Insights
    2.1 Scope of the Study
    2.2 Analyst Insight & Current Market Trends
    2.2.1 Key COPD and Asthma Devices Market Trends
    2.2.2 Market Recommendations
    2.3 Porter's Five Forces Analysis for the COPD and Asthma Devices Market
    2.3.1 Competitive Rivalry
    2.3.2 Threat of New Entrants
    2.3.3 Bargaining Power of Suppliers
    2.3.4 Bargaining Power of Buyers
    2.3.5 Threat of Substitutes
  1. Market Determinants
    3.1 Market Drivers
    3.1.1 Drivers For Global COPD and Asthma Devices Market: Impact Analysis
    3.2 Market Pain Points and Challenges
    3.2.1 Restraints For Global COPD and Asthma Devices Market: Impact Analysis
    3.3 Market Opportunities
    3.3.1 Opportunities For Global COPD and Asthma Devices Market: Impact Analysis
  1. Competitive Landscape
    4.1 Competitive Dashboard – COPD and Asthma Devices Market Revenue and Share by Manufacturers
    • COPD and Asthma Devices Product Comparison Analysis
    • Top Market Player Ranking Matrix

4.2 Key Company Analysis

 4.2.1 Koninklijke Philips N.V. 

      4.2.1.1 Overview 

      4.2.1.2 Product Portfolio 

      4.2.1.3 Financial Analysis 

      4.2.1.4 SWOT Analysis 

      4.2.1.5 Business Strategy 

 4.2.2 ResMed Inc. 

      4.2.2.1 Overview 

      4.2.2.2 Product Portfolio 

      4.2.2.3 Financial Analysis 

      4.2.2.4 SWOT Analysis 

      4.2.2.5 Business Strategy 

 4.2.3 GlaxoSmithKline plc 

      4.2.3.1 Overview 

      4.2.3.2 Product Portfolio 

      4.2.3.3 Financial Analysis 

      4.2.3.4 SWOT Analysis 

      4.2.3.5 Business Strategy 

 4.2.4 AstraZeneca PLC 

      4.2.4.1 Overview 

      4.2.4.2 Product Portfolio 

      4.2.4.3 Financial Analysis 

      4.2.4.4 SWOT Analysis 

      4.2.4.5 Business Strategy 

 4.2.5 Boehringer Ingelheim International GmbH 

      4.2.5.1 Overview 

      4.2.5.2 Product Portfolio 

      4.2.5.3 Financial Analysis 

      4.2.5.4 SWOT Analysis 

      4.2.5.5 Business Strategy 

4.3 Top Winning Strategies by Market Players
4.3.1 Merger and Acquisition
4.3.2 Product Launch
4.3.3 Partnership And Collaboration

  1. Global COPD and Asthma Devices Market Sales Analysis by Product Type ($ Million)
    5.1 Inhalation Devices
    5.2 Nebulizers
    5.3 Airway Clearance Devices
    5.4 Positive Airway Pressure (PAP) Devices
  1. Global COPD and Asthma Devices Market Sales Analysis by Device Category ($ Million)
    6.1 Portable Devices
    6.2 Stationary Devices
  1. Regional Analysis

7.1 North American COPD and Asthma Devices Market Sales Analysis – Product Type | Device Category | End-User | Country ($ Million)
7.1.1 United States
7.1.2 Canada

7.2 European COPD and Asthma Devices Market Sales Analysis – Product Type | Device Category | End-User | Country ($ Million)
7.2.1 UK
7.2.2 Germany
7.2.3 Italy
7.2.4 Spain
7.2.5 France
7.2.6 Russia
7.2.7 Rest of Europe

7.3 Asia-Pacific COPD and Asthma Devices Market Sales Analysis – Product Type | Device Category | End-User | Country ($ Million)
7.3.1 China
7.3.2 Japan
7.3.3 South Korea
7.3.4 India
7.3.5 Australia & New Zealand
7.3.6 ASEAN Countries
7.3.7 Rest of Asia-Pacific

7.4 Rest of the World COPD and Asthma Devices Market Sales Analysis – Product Type | Device Category | End-User | Country ($ Million)
7.4.1 Latin America
7.4.2 Middle East and Africa

  1. Company Profiles

8.1 Aerogen Limited
8.2 AstraZeneca PLC
8.3 Baxter International Inc.
8.4 Beurer GmbH
8.5 BMC Medical Co., Ltd.
8.6 Boehringer Ingelheim International GmbH
8.7 Cipla Limited
8.8 Drive DeVilbiss Healthcare LLC
8.9 Electromed, Inc.
8.10 Fisher & Paykel Healthcare Corporation Limited
8.11 GF Health Products, Inc.
8.12 GlaxoSmithKline plc
8.13 Invacare Corporation
8.14 Löwenstein Medical Technology GmbH + Co. KG
8.15 Lupin Limited
8.16 OMRON Healthcare Co., Ltd.
8.17 PARI GmbH
8.18 Koninklijke Philips N.V.
8.19 ResMed Inc.
8.20 Rossmax International Ltd.
8.21 Sefam S.A.S.
8.22 Teva Pharmaceutical Industries Ltd.
8.23 Trudell Medical International
8.24 Vectura Group plc

1. Global COPD and Asthma Devices Market Research and Analysis by Product Type, 2025–2035 ($ Million) 

2. Global Inhalation Devices Market Research and Analysis by Region, 2025–2035 ($ Million) 

3. Global Nebulizers Market Research and Analysis by Region, 2025–2035 ($ Million) 

4. Global Airway Clearance Devices Market Research and Analysis by Region, 2025–2035 ($ Million) 

5. Global Positive Airway Pressure (PAP) Devices Market Research and Analysis by Region, 2025–2035 ($ Million) 

6. Global COPD and Asthma Devices Market Research and Analysis by Device Category, 2025–2035 ($ Million) 

7. Global Portable COPD and Asthma Devices Market Research and Analysis by Region, 2025–2035 ($ Million) 

8. Global Stationary COPD and Asthma Devices Market Research and Analysis by Region, 2025–2035 ($ Million) 

9. Global COPD and Asthma Devices Market Research and Analysis by End-User, 2025–2035 ($ Million) 

10. Global COPD and Asthma Devices for Hospitals Market Research and Analysis by Region, 2025–2035 ($ Million) 

11. Global COPD and Asthma Devices for Homecare Settings Market Research and Analysis by Region, 2025–2035 ($ Million) 

12. Global COPD and Asthma Devices for Specialty Respiratory Clinics Market Research and Analysis by Region, 2025–2035 ($ Million) 

13. Global COPD and Asthma Devices for Ambulatory Surgical Centers (ASCs) Market Research and Analysis by Region, 2025–2035 ($ Million) 

14. Global COPD and Asthma Devices Market Research and Analysis by Region, 2025–2035 ($ Million) 

15. North America COPD and Asthma Devices Market Research and Analysis by Country, 2025–2035 ($ Million) 

16. North America COPD and Asthma Devices Market Research and Analysis by Product Type, 2025–2035 ($ Million) 

17. North America COPD and Asthma Devices Market Research and Analysis by Device Category, 2025–2035 ($ Million) 

18. North America COPD and Asthma Devices Market Research and Analysis by End-User, 2025–2035 ($ Million) 

19. Europe COPD and Asthma Devices Market Research and Analysis by Country, 2025–2035 ($ Million) 

20. Europe COPD and Asthma Devices Market Research and Analysis by Product Type, 2025–2035 ($ Million) 

21. Europe COPD and Asthma Devices Market Research and Analysis by Device Category, 2025–2035 ($ Million) 

22. Europe COPD and Asthma Devices Market Research and Analysis by End-User, 2025–2035 ($ Million) 

23. Asia-Pacific COPD and Asthma Devices Market Research and Analysis by Country, 2025–2035 ($ Million) 

24. Asia-Pacific COPD and Asthma Devices Market Research and Analysis by Product Type, 2025–2035 ($ Million) 

25. Asia-Pacific COPD and Asthma Devices Market Research and Analysis by Device Category, 2025–2035 ($ Million) 

26. Asia-Pacific COPD and Asthma Devices Market Research and Analysis by End-User, 2025–2035 ($ Million) 

27. Rest of the World COPD and Asthma Devices Market Research and Analysis by Region, 2025–2035 ($ Million) 

28. Rest of the World COPD and Asthma Devices Market Research and Analysis by Product Type, 2025–2035 ($ Million) 

29. Rest of the World COPD and Asthma Devices Market Research and Analysis by Device Category, 2025–2035 ($ Million) 

30. Rest of the World COPD and Asthma Devices Market Research and Analysis by End-User, 2025–2035 ($ Million) 

1. Global COPD and Asthma Devices Market Share by Product Type, 2025 vs 2035 (%) 

2. Global Inhalation Devices Market Share by Region, 2025 vs 2035 (%) 

3. Global Nebulizers Market Share by Region, 2025 vs 2035 (%) 

4. Global Airway Clearance Devices Market Share by Region, 2025 vs 2035 (%) 

5. Global Positive Airway Pressure (PAP) Devices Market Share by Region, 2025 vs 2035 (%) 

6. Global COPD and Asthma Devices Market Share by Device Category, 2025 vs 2035 (%) 

7. Global Portable COPD and Asthma Devices Market Share by Region, 2025 vs 2035 (%) 

8. Global Stationary COPD and Asthma Devices Market Share by Region, 2025 vs 2035 (%) 

9. Global COPD and Asthma Devices Market Share by End-User, 2025 vs 2035 (%) 

10. Global COPD and Asthma Devices Market Share for Hospitals by Region, 2025 vs 2035 (%) 

11. Global COPD and Asthma Devices Market Share for Homecare Settings by Region, 2025 vs 2035 (%) 

12. Global COPD and Asthma Devices Market Share for Specialty Respiratory Clinics by Region, 2025 vs 2035 (%) 

13. Global COPD and Asthma Devices Market Share for Ambulatory Surgical Centers (ASCs) by Region, 2025 vs 2035 (%) 

14. Global COPD and Asthma Devices Market Research and Analysis by Region, 2025–2035 ($ Million) 

15. US COPD and Asthma Devices Market Size, 2025–2035 ($ Million) 

16. Canada COPD and Asthma Devices Market Size, 2025–2035 ($ Million) 

17. UK COPD and Asthma Devices Market Size, 2025–2035 ($ Million) 

18. France COPD and Asthma Devices Market Size, 2025–2035 ($ Million) 

19. Germany COPD and Asthma Devices Market Size, 2025–2035 ($ Million) 

20. Italy COPD and Asthma Devices Market Size, 2025–2035 ($ Million) 

21. Spain COPD and Asthma Devices Market Size, 2025–2035 ($ Million) 

22. Russia COPD and Asthma Devices Market Size, 2025–2035 ($ Million) 

23. India COPD and Asthma Devices Market Size, 2025–2035 ($ Million) 

24. China COPD and Asthma Devices Market Size, 2025–2035 ($ Million) 

25. Japan COPD and Asthma Devices Market Size, 2025–2035 ($ Million) 

26. South Korea COPD and Asthma Devices Market Size, 2025–2035 ($ Million) 

27. Australia & New Zealand COPD and Asthma Devices Market Size, 2025–2035 ($ Million) 

28. ASEAN COPD and Asthma Devices Market Size, 2025–2035 ($ Million) 

29. Rest of Asia-Pacific COPD and Asthma Devices Market Size, 2025–2035 ($ Million) 

30. Latin America COPD and Asthma Devices Market Size, 2025–2035 ($ Million) 

31. Middle East & Africa COPD and Asthma Devices Market Size, 2025–2035 

Choose License Type
    On Discount
Enterprise Custom
  • Printable version
  • No restriction to number of users within the company
CONTACT SALES

100%
Secured Payment

Why buy from us?
  • Covers more than 15 major industries, which are further segmented into 90+ sectors
  • 65% of our clients are loyal customers
  • 120+ countries are covered in analysis
  • currently servicing 1000+ customers globally
  • 100+ paid data sources mined to research
  • Our expert team will assist you with all research need and customization
  • Our expert research analyst will resolve your every query before and after purchasing the report
Related Reports

FAQS

The size of the COPD and Asthma Devices Market in 2025 is estimated to be around $12.5 billion.
North America holds the largest share in the COPD and Asthma Devices Market.
Leading players in the COPD and Asthma Devices Market Includes Koninklijke Philips N.V., ResMed Inc., GlaxoSmithKline plc , AstraZeneca PLC, Boehringer Ingelheim International GmbH, among others.
The COPD and Asthma Devices Market is expected to grow at a CAGR of 6.3% from 2026 to 2035.
Increasing prevalence of respiratory diseases, rising air pollution levels, and growing demand for advanced respiratory care devices are driving the COPD and Asthma Devices Market growth.